Filed: 11/7/2024ACC: 0001085146-24-005432
📋 What this filing means
FIRST TURN MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 38 equity positions with a total reported market value of $631.61M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
38
Positions
$631.61M
Total AUM (reported)
18.05M
Total Shares
Allocation by class
COM$478.14M75.7%
SPONSORED ADR$52.00M8.2%
COM NEW$26.65M4.2%
COM PAR $.01$26.02M4.1%
COMMON STOCK$17.90M2.8%
SPONSORED ADS$16.48M2.6%
CL A$14.43M2.3%
Portfolio Concentration
Top 3$92.27M14.6%
4–10$156.17M24.7%
11–25$237.28M37.6%
Rest$145.89M23.1%
Top 3 weight
14.6%
Top 10 weight
39.3%
Voting Authority Distribution
Total shares with voting rights: 18.05M
Sole
Full voting authority
18.05M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole38
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings38
Rows:
NUVALENT INC
SOLEShares359.11K
TypeSH
Market value$36.74M
5.82%
Sole
359.11K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares54.44K
TypeSH
Market value$29.51M
4.67%
Sole
54.44K
Shared
0.00
None
0.00
INSMED INC
SOLEShares356.45K
TypeSH
Market value$26.02M
4.12%
Sole
356.45K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares647.61K
TypeSH
Market value$25.26M
4.00%
Sole
647.61K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares211.99K
TypeSH
Market value$24.22M
3.84%
Sole
211.99K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares255.29K
TypeSH
Market value$22.94M
3.63%
Sole
255.29K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares1.19M
TypeSH
Market value$22.85M
3.62%
Sole
1.19M
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares150.59K
TypeSH
Market value$22.49M
3.56%
Sole
150.59K
Shared
0.00
None
0.00
NATERA INC
SOLEShares155.65K
TypeSH
Market value$19.76M
3.13%
Sole
155.65K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares254.80K
TypeSH
Market value$18.64M
2.95%
Sole
254.80K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares353.38K
TypeSH
Market value$18.06M
2.86%
Sole
353.38K
Shared
0.00
None
0.00
TRANSMEDICS GROUP INC
SOLEShares114.25K
TypeSH
Market value$17.94M
2.84%
Sole
114.25K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares214.30K
TypeSH
Market value$17.90M
2.83%
Sole
214.30K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares178.93K
TypeSH
Market value$16.55M
2.62%
Sole
178.93K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares572.93K
TypeSH
Market value$16.48M
2.61%
Sole
572.93K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares35.22K
TypeSH
Market value$16.38M
2.59%
Sole
35.22K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares315.82K
TypeSH
Market value$15.78M
2.50%
Sole
315.82K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares357K
TypeSH
Market value$15.45M
2.45%
Sole
357K
Shared
0.00
None
0.00
MERUS N V
SOLEShares308.01K
TypeSH
Market value$15.39M
2.44%
Sole
308.01K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares1.45M
TypeSH
Market value$14.87M
2.35%
Sole
1.45M
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares30.25K
TypeSH
Market value$14.86M
2.35%
Sole
30.25K
Shared
0.00
None
0.00
HARROW INC
SOLEShares326.58K
TypeSH
Market value$14.68M
2.32%
Sole
326.58K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares326.49K
TypeSH
Market value$14.43M
2.28%
Sole
326.49K
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares562.39K
TypeSH
Market value$14.32M
2.27%
Sole
562.39K
Shared
0.00
None
0.00
GERON CORP
SOLEShares3.12M
TypeSH
Market value$14.19M
2.25%
Sole
3.12M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NUVALENT INCSOLE | COM | 359.11K | SH | $36.74M 5.82% | 359.11K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 54.44K | SH | $29.51M 4.67% | 54.44K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 356.45K | SH | $26.02M 4.12% | 356.45K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 647.61K | SH | $25.26M 4.00% | 647.61K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 211.99K | SH | $24.22M 3.84% | 211.99K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 255.29K | SH | $22.94M 3.63% | 255.29K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.19M | SH | $22.85M 3.62% | 1.19M | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 150.59K | SH | $22.49M 3.56% | 150.59K | 0.00 | 0.00 |
NATERA INCSOLE | COM | 155.65K | SH | $19.76M 3.13% | 155.65K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 254.80K | SH | $18.64M 2.95% | 254.80K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 353.38K | SH | $18.06M 2.86% | 353.38K | 0.00 | 0.00 |
TRANSMEDICS GROUP INCSOLE | COM | 114.25K | SH | $17.94M 2.84% | 114.25K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 214.30K | SH | $17.90M 2.83% | 214.30K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 178.93K | SH | $16.55M 2.62% | 178.93K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 572.93K | SH | $16.48M 2.61% | 572.93K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 35.22K | SH | $16.38M 2.59% | 35.22K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 315.82K | SH | $15.78M 2.50% | 315.82K | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 357K | SH | $15.45M 2.45% | 357K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 308.01K | SH | $15.39M 2.44% | 308.01K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 1.45M | SH | $14.87M 2.35% | 1.45M | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 30.25K | SH | $14.86M 2.35% | 30.25K | 0.00 | 0.00 |
HARROW INCSOLE | COM | 326.58K | SH | $14.68M 2.32% | 326.58K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 326.49K | SH | $14.43M 2.28% | 326.49K | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 562.39K | SH | $14.32M 2.27% | 562.39K | 0.00 | 0.00 |
GERON CORPSOLE | COM | 3.12M | SH | $14.19M 2.25% | 3.12M | 0.00 | 0.00 |
Page 1 of 2